These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 966163)

  • 21. What happens in the skin? Integrating skin permeation kinetics into studies of developmental and reproductive toxicity following topical exposure.
    Dancik Y; Bigliardi PL; Bigliardi-Qi M
    Reprod Toxicol; 2015 Dec; 58():252-81. PubMed ID: 26475253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional intestinal drug permeation: biopharmaceutics and drug development.
    Lennernäs H
    Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro estimates of topical bioavailability.
    Ando HY; HO NF; Higuchi WI
    J Pharm Sci; 1977 May; 66(5):755-7. PubMed ID: 874771
    [No Abstract]   [Full Text] [Related]  

  • 24. History of pharmacokinetics.
    Wagner JG
    Pharmacol Ther; 1981; 12(3):537-62. PubMed ID: 7025032
    [No Abstract]   [Full Text] [Related]  

  • 25. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of cholestasis on drug elimination: pharmacokinetics.
    Harrison LI; Gibaldi M
    J Pharm Sci; 1976 Sep; 65(9):1346-8. PubMed ID: 966151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of frozen and reconstituted cattle and human skin as barriers to drug penetration.
    Pitman IH; Rostas SJ
    J Pharm Sci; 1982 Apr; 71(4):427-30. PubMed ID: 7086651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic and empirical modeling of skin permeation of drugs.
    Yamashita F; Hashida M
    Adv Drug Deliv Rev; 2003 Sep; 55(9):1185-99. PubMed ID: 12954198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vehicle effects in percutaneous absorption.
    Idson B
    Drug Metab Rev; 1983; 14(2):207-22. PubMed ID: 6341025
    [No Abstract]   [Full Text] [Related]  

  • 30. [Application of pharmacokinetics in clinical pharmacology and biopharmaceutics].
    Xi NZ
    Yao Xue Xue Bao; 1983 Feb; 18(2):151-60. PubMed ID: 6613595
    [No Abstract]   [Full Text] [Related]  

  • 31. Modelling dermal drug distribution after topical application in human.
    Anissimov YG; Roberts MS
    Pharm Res; 2011 Sep; 28(9):2119-29. PubMed ID: 21523512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetics as a basic pharmacological problem].
    Dettli L
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():59-73. PubMed ID: 4906026
    [No Abstract]   [Full Text] [Related]  

  • 33. [Biopartitioning micellar chromatography: its application in evaluating drug membrane transport and activity].
    Mao JJ; Sun J; He ZG
    Yao Xue Xue Bao; 2005 Oct; 40(10):865-70. PubMed ID: 16408799
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics and bioavailability.
    Wagner JG
    Triangle; 1975; 14(3-4):101-8. PubMed ID: 1209729
    [No Abstract]   [Full Text] [Related]  

  • 35. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drugs and the organism (V). Biopharmaceutic models and in vivo/in vitro correlation].
    Pflegel P
    Pharmazie; 1983 Oct; 38(10):671-8. PubMed ID: 6657736
    [No Abstract]   [Full Text] [Related]  

  • 37. Preparation and evaluation of 5, 9-dimethyl-2-cyclopropyl-2-decanol as a penetration enhancer for drugs through rat skin.
    Khan GM; Hussain A; Hanif RM
    Pak J Pharm Sci; 2011 Oct; 24(4):451-7. PubMed ID: 21959804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. QSAR analysis of interstudy variable skin permeability based on the "latent membrane permeability" concept.
    Fujiwara S; Yamashita F; Hashida M
    J Pharm Sci; 2003 Oct; 92(10):1939-46. PubMed ID: 14502534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards a correlation between drug properties and in vitro transdermal flux variability.
    Frum Y; Khan GM; Sefcik J; Rouse J; Eccleston GM; Meidan VM
    Int J Pharm; 2007 May; 336(1):140-7. PubMed ID: 17182201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modelling skin permeability with micellar liquid chromatography.
    Waters LJ; Shahzad Y; Stephenson J
    Eur J Pharm Sci; 2013 Nov; 50(3-4):335-40. PubMed ID: 23948555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.